Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03840200
Title A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

fallopian tube cancer

peritoneum cancer

prostate adenocarcinoma

endometrioid ovary carcinoma

ovarian clear cell carcinoma

ovarian serous carcinoma

Her2-receptor negative breast cancer

Therapies

Ipatasertib + Rucaparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.